Electronic nicotine delivery systems (ENDS, e-cigarettes) are increasingly used for the selfadministration of nicotine by various human populations, including previously nonsmoking adolescents.
Introduction
Exponential growth in the use of electronic nicotine delivery systems (ENDS or e-cigarette) for the self-administration of nicotine has been observed across numerous populations within the US (McCarthy, 2013; Wong and Fan, 2018) and worldwide (Brown et al., 2014; Fraser et al., 2018; Goniewicz and Zielinska-Danch, 2012; Sarfraz et al., 2018; Wang et al., 2018; Yoong et al., 2018) in recent years.
Evidence suggests that ENDS are being used in cessation attempts (Kalkhoran and Glantz, 2016; Mantey et al., 2017; Weaver et al., 2018) as well as by people who choose to continue their nicotine habit either for potential / perceived health benefits (Spears et al., 2018; Stokes et al., 2018) or social acceptability (Berg et al., 2014; Romijnders et al., 2018) compared with tobacco smoking. Widespread availability of such devices, particularly with adolescent age ranges, sparks concern that ENDS may facilitate the development of nicotine dependence without any prior use of combustible tobacco products (Fulton et al., 2018; Martinasek et al., 2018) and may even increase the odds of later initiation of combustible tobacco use (East et al., 2018; Loukas et al., 2018; Primack et al., 2018) , a relationship that may be mediated by the nicotine content in the e-cigarettes (Goldenson et al., 2017) .
There are as yet relatively few studies of the effects of ENDS in rodent models, however one recent study showed e-cigarette based vapor inhalation of nicotine in mice reduced body temperature and locomotor activity (Lefever et al., 2017) which demonstrates feasibility of the approach. The paucity of models is underlined by the fact that several recent studies have resorted to parenteral injection of ecigarette refill liquids to determine effects in rats (Bunney et al., 2018; El Golli et al., 2016; Golli et al., 2016; Harris et al., 2015; LeSage et al., 2016) . Inhalation administration of nicotine is possible, since one study showed that inhalation of air bubbled through an aqueous solution of nicotine produces nicotine dependence and facilitates the acquisition of subsequent nicotine intravenous self-administration (Gilpin et al., 2012) . Finally, a few studies have examined the effects of inhalation of e-cigarette generated vapor on toxicological markers (Phillips et al., 2017; Werley et al., 2016) , wound healing (Rau et al., 2017) and laryngeal mucosa (Salturk et al., 2015) in rats. This relative lack of information means that it is of pressing and significant interest to develop and validate experimental methods that can support a range of ENDS studies. We have recently developed a system capable of delivering behaviorally significant doses of THC (Javadi-Paydar et al., 2018a; Nguyen et al., 2016b; Nguyen et al., 2018) , as well as methamphetamine, mephedrone and 3,4-methylenedioxypyrovalerone (Nguyen et al., 2016a; Nguyen et al., 2017) to rats via the inhalation of ENDS vapor. This system has also been shown to support the selfadministration of sufentanil with rats reaching dependence-inducing levels of drug intake via inhalation (Vendruscolo et al., 2018) .
This study was designed to first determine if the inhalation of nicotine using this vapor inhalation system produces either hypothermic or locomotor effects in rats. Injected nicotine has previously been shown to reduce body temperature and increase spontaneous locomotion in rats (Bryson et al., 1981; Clemens et al., 2009; Green et al., 2003; Levin et al., 2003) , thus these measures were selected for initial validation. These have the additional advantages of supporting indirect comparison with our prior reports on the effects of inhaled THC (Javadi-Paydar et al., 2018a; Nguyen et al., 2016b; Nguyen et al., 2018) and psychomotor stimulants (Nguyen et al., 2016a; Nguyen et al., 2017) .
A second goal was to determine if there were interactive effects of the inhalation of threshold doses of THC and nicotine. Many consumers use hollowed out cigars filled with cannabis ("blunts") to dose themselves with THC (Eggers et al., 2017; Ream et al., 2008; Schauer et al., 2017; Timberlake, 2009) and other individuals co-use tobacco and marijuana sequentially in a manner that would expose them simultaneously to both nicotine and THC (Agrawal et al., 2012) . This practice may leave some users at higher risk for cannabis dependence (Ream et al., 2008) . The burgeoning use of e-cigarette devices to consume THC via cannabis extracts makes it trivial for users to titrate drug combinations if desired. It can be difficult to identify independent versus additive risks from heterogenous human populations who use both tobacco and cannabis; well controlled preclinical models can be useful for identifying independent or interactive effects of nicotine and THC co-administration. Therefore additional studies were designed to determine if vapor inhalation of THC modified the effects of nicotine inhalation.
Methods

Subjects
Male (N=8) Sprague-Dawley (Harlan, Livermore CA) rats were housed in humidity and temperature-controlled (23±2 °C) vivaria on 12:12 hour light:dark cycles. Rats had ad libitum access to food and water in their home cages and all experiments were performed in the rats' scotophase. Rats entered the laboratory at 10-11 weeks of age. All procedures were conducted under protocols approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.
Drugs
Rats were exposed to vapor derived from nicotine bitartrate (1, 10, 30 mg/mL) or ∆ 9tetrahydrocannabinol (THC; 12.5, 25 mg/mL) dissolved in a propylene glycol (PG) vehicle. The ethanolic THC stock was aliquoted in the appropriate volume, the ethanol evaporated off and the THC was then dissolved in the PG to achieve target concentrations. Four 10-s vapor puffs were delivered with 2-s intervals every 5 minutes, which resulted in use of approximately 0.1 mL in a 30 minutes exposure session. Mecamylamine HCl was dissolved in saline for intraperitoneal injection (2 mg/kg). Nicotine and mecamylamine were obtained from Sigma-Aldrich (St. Louis, MS) and the THC was provided by the U.S. National Institute on Drug Abuse.
Radiotelemetry
Rats were anesthetized with an isoflurane/oxygen vapor mixture (isoflurane 5% induction, 1-3% maintenance) and sterile radiotelemetry transmitters (Data Sciences International, St. Paul, MN; TA-F40) were implanted in the abdominal cavity through an incision along the abdominal midline posterior to the xyphoid space as previously described (Javadi-Paydar et al., 2018b) . Experiments were initiated four weeks after surgery. Activity and temperature responses were evaluated in the vapor inhalation chambers in a dark testing room, separate from the vivarium, during the (vivarium) dark cycle. The telemetry recording plates were placed under the vapor inhalation chambers thus data were collected on a 5 minute schedule throughout the experiment.
Inhalation Apparatus
Sealed exposure chambers were modified from the 259mm X 234mm X 209mm Allentown, Inc (Allentown, NJ) rat cage to regulate airflow and the delivery of vaporized drug to rats using e-cigarette cartridges (Protank 3 Atomizer, MT32 coil operating at 2.2 ohms, by Kanger Tech; Shenzhen Kanger Technology Co.,LTD; Fuyong Town, Shenzhen, China) as has been previously described (Nguyen et al., 2016a; Nguyen et al., 2016b) . An e-vape controller (Model SSV-1; 3.3 volts; La Jolla Alcohol Research, Inc, La Jolla, CA, USA) was triggered to deliver the scheduled series of puffs by a computerized controller designed by the equipment manufacturer (Control Cube 1; La Jolla Alcohol Research, Inc, La Jolla, CA, USA). The chamber air was vacuum controlled by a chamber exhaust valve (i.e., a "pull" system) to flow room ambient air through an intake valve at ~1 L per minute. This also functioned to ensure that vapor entered the chamber on each device triggering event. The vapor stream was integrated with the ambient air stream once triggered.
Experiments
Experiment 1 (Nicotine Dose)
The effects of inhaling three concentrations of nicotine (1, 10, 30 mg/mL) were compared with the inhalation of the PG vehicle. A single 30 minute inhalation interval was conducted each test session and doses were evaluated in a balanced order with 3-4 days minimum between test days for this and all subsequent experiments.
Experiment 2 (Repeated Nicotine Inhalation)
Since human tobacco smokers tend to smoke multiple times per day, an experiment was conducted to determine the effects of inhaling PG vs nicotine (30 mg/mL) for 15 minutes every hour for four total inhalation bouts. Following Experiment 4, this condition was repeated, including pretreatments of saline versus mecamylamine (2 mg/kg, i.p.) for four total conditions, assessed in a counter-balanced order. In this latter experiment pretreatments were administered 15 minutes prior to the start of inhalation, i.e., in the middle of the usual baseline interval.
Experiment 3 (Nicotine combined with THC)
The effects of inhaling vapor from PG, nicotine (30 mg/mL), THC (25 mg/mL) or the combination of drugs in a 30 minute session were evaluated in a counter-balanced order.
Experiment 4 (Repeated nicotine combined with THC)
The effects of inhaling vapor from PG, nicotine (30 mg/mL), THC (12.5 mg/mL) or the combination of drugs for 15 minutes every hour, for four total inhalation epochs, was assessed in this experiment. The inhalation / dose conditions were administered in a counter-balanced order.
Data Analysis
Temperature and activity rate (counts per minute) were collected via the radiotelemetry system 
Results
Experiment 1 (Nicotine Dose)
The inhalation of nicotine in a 30 minute exposure reduced the body temperature of rats as is depicted in Figure 1A . Statistical analysis of the body temperature confirmed significant effects of Time Figure 3B) and a significant attenuation of the hypothermic response to nicotine was confirmed after the fourth vapor interval (Figure 3A) .
Figure 2: Mean (N=8; ±SEM) A) temperature and B) locomotor activity after inhalation of vapor from the propylene glycol (PG) vehicle or nicotine (NIC; 30 mg/mL) in four successive 15 minute intervals (indicated with arrows).
Grey symbols indicate a significant difference from the point time point immediately prior to each inhalation interval within condition. Significant differences from the PG condition (only) are indicated with *. Open symbols indicate significant difference from preceding timepoint and PG. Base = baseline.
Experiment 3 (Nicotine combined with THC)
The inhalation of nicotine (30 mg/mL), THC (25 mg/mL) or the combination in a 30 minute session reduced the rats' body temperature, as is depicted in 
Experiment 4 (Repeated Nicotine combined with THC)
Repetition of four 15 minute inhalation intervals resulted in detectable effects of nicotine, THC and the combination of the two (Figure 5A) . The analysis confirmed significant effects of Time [F (9, 63) .0001] on body temperature. The post hoc test further confirmed that body temperature was lower during the combined condition compared with the PG or nicotine inhalation 90-270 minutes after the start of the first inhalation period. Temperature was also reduced in the THC (12.5 mg/mL) condition, compared with PG or nicotine inhalation from 180-270 minutes after the start of the first inhalation.
Spontaneous locomotor activity was increased by both THC and nicotine inhalation (Figure 5B) PG vehicle, nicotine (NIC; 30 mg/mL), 25 mg/mL) or the combination for 30 minutes. Open symbols indicate a significant difference from both PG at a given time-point and the within-treatment baseline, while shaded symbols indicate a significant difference from the baseline only. Significant differences from the PG condition (only) are indicated with *. A significant difference from both NIC and THC conditions is indicated by & and from NIC by #.
Discussion
The study found that a recently developed ENDS-based model of vapor inhalation is capable of delivering behaviorally significant amounts of nicotine to male Sprague-Dawley rats, resulting in both hyperactivity and hypothermia responses. The initial experiments found that a 30 mg/mL concentration in the vapor vehicle was necessary to produce robust effects (Figure 1) and a hypothermic response was found after either a single 30 minute exposure or four 15 minute exposures administered at hourly intervals. Hyperlocomotor responses in this model were observed most consistently with a repeated 15 minute exposure every hour (Figure 2) , compared with a single 30 minute inhalation interval. This was most likely due to an increase in locomotor activity that followed the first PG delivery of a given session, thus obscuring locomotor effects on nicotine in the single-exposure paradigm. This response to the vehicle was attenuated on subsequent vapor deliveries within the same session in the quadruple exposure, thus the pharmacological effect of the nicotine inhalation was unmasked. Hypothermia is produced by parenteral injection of nicotine in rats (Levin et al., 2003) as is hyperlocomotion (Bryson et al., 1981; Clemens et al., 2009; Green et al., 2003) and decreased body temperature was observed after vapor inhalation of nicotine in mice (Lefever et al., 2017) . The effects of inhaled nicotine in this study were shown to be mediated by the nicotinic acetylcholine receptor (nAChR) since they were attenuated (temperature) or blocked entirely (locomotion) by pre-treatment with mecamylamine (Figure 3) . Thus, these data show that physiologically significant doses of nicotine were delivered to the rats using this method.
Due to reasonably frequent co-exposure of human cannabis users to nicotine (Cooper and Haney, 2009; Eggers et al., 2017; Ream et al., 2008; Schauer et al., 2017; Timberlake, 2009 ), this study further determined the effects of co-exposure to THC and nicotine via vapor inhalation. Prior work with our inhalation model demonstrated consistent, dose-dependent hypothermic effects of THC inhalation and an inconsistent suppression of locomotor behavior in male and female Wistar, as well as male Sprague-Dawley, rats (Javadi-Paydar et al., 2018a; Nguyen et al., 2016b; Nguyen et al., 2018) . Parenteral injection of nicotine has previously been found to increase the hypothermia associated with injected THC (Pryor et al., 1978; Valjent et al., 2002) , thus there was reason to expect similar effects in this model.
Overall, the present data are most consistent with independent and additive, rather than interactive, effects of the two drugs. First, the body temperature observed after a single 30 minute exposure decreased more rapidly after nicotine (30 mg/mL) inhalation and less rapidly after THC (25 mg/mL) inhalation, but reached the same nadir. When the combination of drugs was available in the single 30 minute exposure epoch (Figure 4) , the initial hypothermia was rapid and of the same magnitude as the response to nicotine alone in the first 30 minutes. An additional decrease over the next 30 minutes appeared to parallel the effect of THC alone, albeit starting from the lower, nicotine-induced temperature.
In the study in which four 15-minute inhalation epochs were administered at hourly intervals, temperature was most consistently reduced in the combination condition and only declined in the THC (12.5 mg/mL) condition after the third exposure (Figure 5) . Nicotine inhalation increased locomotor activity only in the nicotine-only condition in these two experiments and did not counter the locomotor suppressing effects of THC, where present in the 30-minute, 25 mg/mL experiment. The lowest exposure to THC, i.e. in the first 15 minute 12.5 mg/mL inhalation epoch, elevated activity compared with the vehicle inhalation but with further inhalation in the same session, THC suppressed activity. There was no evidence in that experiment that nicotine co-administration further increased the locomotor stimulation produced by the lowest dose of THC and no evidence nicotine could prevent the locomotor suppression associated with additional THC inhalation within the session.
In conclusion, these studies validate the use of this model for the study of the effects of ENDS based inhalation of nicotine in rats. We further show that combined inhalation of nicotine and THC produces effects that are most consistent with an interpretation of independent, rather than interactive, effects.
